Modeling Patient-Derived Breast Cancer in three dimensions: Patient-derived tumorospheres as a promising ex vivo Experimental Model
Year: 2026
Type: other
Abstract: Patient-derived spheroids and organoids are increasingly used in cancer research to reduce animal experimentation and enhance reproducibility. However, these models do not recapitulate the tumor microenvironment, which prevents from taking interpatient variability into account. To overcome this limitation, we developed a patient-derived 3D breast cancer model from fresh surgical specimens, termed patient-derived tumorosphere (PDTs). Immunohistochemistry revealed strong concordance in molecular markers, as well as in immune and endothelial cell representation, between PDTs and their corresponding primary tumors. Second harmonic generation and autofluorescence microscopy confirmed de novo synthesis of extracellular matrix components. Infrared micro-spectroscopy combined with K-means clustering revealed structural heterogeneity within PDTs but morpho-spectroscopic similarity to native tissue. Drug-response assays with paclitaxel suggested increased cytotoxicity with drug concentrations and exposure time. This preliminary methodological study indicates that PDTs retain cellular heterogeneity and extracellular-matrix-associated signals from the parental tumors, highlighting their potential as a rapid and scaffold-free relevant model for personalized therapy research and reduction of animal use in preclinical studies.
Source: HAL
Institutions: UniCancer Group, Institut Jean Godinot, Immuno-Régulation des Maladies Auto- immunes Inflammatoires et Cancer, Université de Reims Champagne-Ardenne, BioSpectroscopie Translationnelle, Université Mohammed VI Polytechnique, Centre National de la Recherche Scientifique, Matrice Extracellulaire et Dynamique Cellulaire MEDyC
Language: English
Topic: Cancer Cells and Metastasis
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: green
OpenAlex ID: W7204671941
